(B) Percentage of CD11b+cells among the four different DC subsets, irrespective of targeting. by the TLR7 agonist imiquimod. Complete removal of the site where ovalbumin-coupled
(B) Percentage of CD11b+cells among the four different DC subsets, irrespective of targeting. by the TLR7 agonist imiquimod. Complete removal of the site where ovalbumin-coupled